China's Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates. With Friday's announceme..
The Ministry of Public Health has encouraged individuals to get the booster vaccine against Tdap (tetanus, diphtheria and pertussis), as the immunity provided by childhood vaccinations begins to wear off during adolescence. Health a...
A second Global COVID-19 Summit will be held virtually next month for countries to discuss efforts to end the pandemic and prepare for future health threats, according to a joint statement on Monday. "The emergence and spread of new variants,..
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech (SVA.O) to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday. Scientists worldwide are racing to ..
The State of Qatar stressed that the Coronavirus (Covid-19) pandemic represented the greatest health challenge facing humanity for decades, and that there is still a need to make more efforts to promote equality in the availability of vaccines and en..
Sweden will give a fourth shot of COVID-19 vaccine to people aged 65 and above to boost their defences against the disease, the health agency said on Monday. "For people aged 65 and over, it is now four months since the previous vaccine dose,..
The Ministry of Public Health has approved the use of a fourth vaccine dose of Pfizer/BioNTech and Moderna COVID-19 vaccines for individuals at high-risk of severe infection. The fourth dose is only applicable to individuals 60 years of age ..
Vaccine inequity poses threats to vulnerable communities and the global community, as discussed at yesterday's Doha Forum. Panellists of ‘Vaccine Distribution: Collaborative Solutions for an Equitable System’ discussed the reasons ..
The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Antibodies in kids after COVID last 6 months or more M..